Carl Zeiss to acquire Acri.Tec

Article

Carl Zeiss Meditec has announced that it intends to acquire Acri.Tec.

Carl Zeiss Meditec has announced that it intends to acquire Acri.Tec.

Acri.Tec generated sales revenues in the 2006 financial year of €15.4 million. The enterprise value calculated for the company totals €24 million and has to be reduced by the net financial debt at the closing date in order to determine the final purchase price.

Carl Zeiss will acquire all Acri.Tec shares against a cash settlement. The transaction is subject to approval by the German anti-trust authority but, once this approval has been given, the acquisition is expected to be closed during October 2007.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.